8-K item 3.01
Exchange deficiency notices
Open Nasdaq and NYSE listing deficiency notices and their cure deadlines as stated in the filing.
Open notices by deadline 12
| Company | Rule | Notice | Cure by | Filing |
|---|---|---|---|---|
| SkinHealth Systems | Stock under $1Nasdaq rule 5550(a)(2) | May 12, 2026 (8-K filed) | Nov 4, 2026 | 8-K item 3.01 |
| Envoy Medical | Stock under $1Nasdaq rule 5550(a)(2) | May 19, 2026 | Nov 16, 2026 | 8-K item 3.01 |
| Vivos Therapeutics | Stock under $1Nasdaq rule 5550(a)(2) | Jun 5, 2026 | Dec 2, 2026 | 8-K item 3.01 |
| Cytosorbents | Market value too lowNasdaq rule 5550(b)(2) | Jun 29, 2026 | Dec 28, 2026 | 8-K item 3.01 |
| InspireMD | Stock under $1Nasdaq rule 5550(a)(2) | Jul 17, 2026 | Jan 13, 2027 | 8-K item 3.01 |
| Bone Biologics | Stock under $1Nasdaq rule 5550(a)(2) | Sep 10, 2026 | Mar 9, 2027 | 8-K item 3.01 |
| Hyperfine | Stock under $1Nasdaq rule 5450(a)(1) | Sep 17, 2026 | Mar 16, 2027 | 8-K item 3.01 |
| SANUWAVE Health | Market value too lowNasdaq rule 5450(b)(2)(A) | Sep 25, 2026 (8-K filed) | Mar 22, 2027 | 8-K item 3.01 |
| Innovative Eyewear | Stock under $1Nasdaq rule 5550(a)(2) | Oct 15, 2026 (8-K filed) | Apr 7, 2027 | 8-K item 3.01 |
| Lucid Diagnostics | Stock under $1Nasdaq rule 5550(a)(2) | Oct 16, 2026 (8-K filed) | Apr 12, 2027 | 8-K item 3.01 |
| Picard Medical | Stockholders' equity too lowNYSE American rule 1003(a)(i) | May 15, 2026 | Nov 8, 2027 | 8-K item 3.01 |
| Picard Medical | Stockholders' equity too lowNYSE American rule 1003(a)(ii) | May 8, 2026 | Nov 8, 2027 | 8-K item 3.01 |
Data through Nov 2, 2026, the newest 8-K item 3.01 SEC Tracker has read.
Dates and rules are as stated in each 8-K item 3.01 filing; a blank means the filing did not state one. Read the filing for the full terms. Not investment advice. Not affiliated with the U.S. SEC. Listing deadlines on the calendar · All screens